GlassScriptPhysician profile
Joseph Ayat
NPI 1710320593
$5,813.85
in general payments reported to CMS, 2019-2025
29 companies · $1,462 in 2025
The $1,462 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $700 · 2020: $139 · 2021: $923 · 2022: $204 · 2023: $1,682 · 2024: $703 · 2025: $1,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,078 · Travel and Lodging: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,077.86 |
| Travel and Lodging | $769.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,441.44 | 2019-2025 | Impella |
| Medtronic, INC. | $1,398.01 | 2021-2025 | Resolute Onyx, Symplicity G3, Onyx Frontier |
| Boston Scientific Corporation | $316.89 | 2019-2024 | Avvigo Guidance System, Stingray |
| Edwards Lifesciences Corporation | $298.35 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Esperion Therapeutics, INC. | $246.33 | 2021-2023 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $212.67 | 2019-2020 | |
| Abbott Laboratories | $201.01 | 2021 | |
| Teleflex LLC | $189.87 | 2023-2025 | Turnpike, Guideliner, Trapliner |
| Atricure, INC. | $178.37 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Terumo Medical Corporation | $171.63 | 2019-2023 | Heartrail |
| Organogenesis INC. | $145.59 | 2025 | Puraply Wound Matrix |
| Philips North America LLC | $130.61 | 2021 | |
| Janssen Pharmaceuticals, INC | $129.75 | 2021-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $124.05 | 2021 | |
| Cardiovascular Systems INC. | $107.15 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $91.53 | 2025 | Indigo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.79 | 2023-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $53.20 | 2025 | |
| Shockwave Medical, INC | $49.58 | 2021 | |
| Amgen INC. | $37.01 | 2023-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $33.51 | 2024-2025 | Verquvo |
| Medtronic Vascular, INC. | $32.68 | 2020 | |
| Novo Nordisk INC | $27.90 | 2025 | Wegovy |
| Ancora Heart, INC. | $26.68 | 2025 | Accucinch |
| Angiodynamics, INC. | $22.47 | 2025 | Alphavac |
| Lantheus Medical Imaging, INC. | $22.45 | 2023 | Definity |
| Tactile Systems Technology INC | $21.44 | 2023 | Flexitouch Plus, Entre Plus |
| Pfizer INC. | $18.52 | 2025 | |
| Chiesi USA, INC. | $18.37 | 2023 | Cleviprex, Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Ayat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.